Target intelligence / Profile preview

Lamin B1 (LMNB1)

Target
LMNB1
Molecular classification
type V intermediate filament protein, nuclear lamina protein, structural protein, B-type lamin
01

Overview

Lamin B1 is a type V intermediate filament protein and a member of the lamin family that forms the nuclear lamina, a network underlying the inner nuclear membrane in metazoan cells. It serves crucial roles in maintaining nuclear shape, mechanical stability, and structural support, organizes chromatin and regulates genome function and gene expression, and is essential for proper cell cycle progression, DNA replication, and DNA repair. Lamin B1 is especially important for brain development and function: duplication of the LMNB1 gene causes autosomal dominant adult-onset demyelinating leukodystrophy, while deficiency leads to developmental deficits, including neural tube defects and abnormal neuronal dendrite morphology. Lamin B1 is anchored to the nuclear envelope and is permanently farnesylated, distinguishing it from A-type lamins, and it interacts with chromatin regions called lamin-associated domains (LADs) associated with gene repression. Altered Lamin B1 levels serve as biomarkers for cellular senescence, aging, and certain neuropathological states. Although it is critical for cell viability and genome organization, it is not currently considered a direct pharmacological target.

Other names
Lamin-B1LB1Nuclear lamin B1LMNB1
02

Biological functions

maintenance of nuclear shape and stabilitychromatin organization and condensationregulation of gene expression and alternative splicingDNA replication and repaircell cycle progressionnuclear positioningdendrite and neuronal development
03

Disease associations

adult-onset autosomal dominant leukodystrophyneural tube defects (via loss-of-function mutation)aging and senescence marker
04

Biomarkers

loss of Lamin B1 as a biomarker for cellular senescenceincreased levels in response to certain neuropathologies and senescent statesgenetic duplication in diagnostic panels for leukodystrophy

Beyond the preview

Go deeper on Lamin B1 (LMNB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lamin B1 (LMNB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call